BridgeMD
New treatment option for Chronic Pain
Official title Mechanisms of Mindfulness Meditation and Self-Hypnosis for Pain in Older Adults With Chronic Pain
ClinicalTrials.gov ID: NCT06957743
What this study is testing
- What it's testing
- The goal of this study is to better understand how two common psychological treatments for pain work in the brain of older adults living with chronic pain. This study will: 1.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 and older
You may be able to join if
- be ≥60 years of age;
- have self-reported chronic pain (≥3-months, with pain experienced on ≥ 50% of days);
- endorse an average intensity of pain ≥3 on a 0-10 numerical rating scale (NRS) for most days of the previous 3-months;
- be able to read, speak, and understand English;
- be naïve to meditation and hypnosis:
You likely can't join if
- have a history of a medical condition that could produce an abnormal EEG (e.g., epilepsy, history of traumatic brain injury);
- have an EEG confounder (e.g., congenital or acquired skull defects, missing sections or holes in the skull, or plates, screws, or other implants...
- have metals in the body (e.g., pacemakers and/or cochlear implant) that are not allowed by IBIC MRI technicians;
- self-report claustrophobia or other contraindications to MRI scanning;
- have uncontrolled hypertension;
- have a primary chronic pain condition of headache;
See the full eligibility criteria
- be ≥60 years of age;
- have self-reported chronic pain (≥3-months, with pain experienced on ≥ 50% of days);
- endorse an average intensity of pain ≥3 on a 0-10 numerical rating scale (NRS) for most days of the previous 3-months;
- be able to read, speak, and understand English;
- be naïve to meditation and hypnosis:
- never received formal training in or attended a mindfulness meditation or therapeutic hypnosis course;
- have not practiced meditation (e.g., mindfulness meditation, Zen, Buddhism, or meditation applications such as certain types of CALM meditation; or therapeutic hypnosis (e.g., hypnosis applications) in the past 6-months;
- \<20-min. practice/week of meditation or therapeutic hypnosis (not described above) over the past 6-months;
- if currently taking analgesic or psychotropic medication, medication must have been stabilized for ≥4-weeks prior to this study and does not anticipate changes in the medication during the study;
- access to a private place with adequate internet reception to support participation in intervention training sessions;
- not currently participating in another clinical trial or treatment study for chronic pain and willing to refrain from participation in any other clinical trial or treatment study for chronic pain during active...
- willing, able, and committed to participate in an in-person EEG, and two MRI/fMRI scans; and
- able to use an electronic device (e.g., smart phone, tablet, computer) independently to access email and webpages or have someone available in their home who can help them with initial session set-up and then leave for...
- have a history of a medical condition that could produce an abnormal EEG (e.g., epilepsy, history of traumatic brain injury);
- have an EEG confounder (e.g., congenital or acquired skull defects, missing sections or holes in the skull, or plates, screws, or other implants within the skull or brain) that would interfere with reliable EEG data...
- have metals in the body (e.g., pacemakers and/or cochlear implant) that are not allowed by IBIC MRI technicians;
- self-report claustrophobia or other contraindications to MRI scanning;
- have uncontrolled hypertension;
- have a primary chronic pain condition of headache;
- have chronic pain due to malignancy (e.g., cancer) or a chronic pain condition for which surgery is recommended and/or planned;
- alcohol abuse (operationalized as scoring ≥5 (male) or ≥4 (female) and responds that they have three or more standard drinks on a typical day or they have six or more drinks on one occasion less than monthly or greater...
- severe cognitive impairment defined as ≥2 errors on the 6-Item Cognitive Impairment test or show signs of cognitive impairment on the Montreal Cognitive Assessment (MoCA, using demographically-adjusted normative...
- currently receiving other psychosocial treatments for any pain condition (as this may influence these treatment results);
- self-report previous participation in an experimental pain study;
- report \<2 on a 0-10 NRS for pain intensity in response to experimental "heat" pain stimuli (in order to avoid floor effects and to ensure participants are not too insensitive to thermal pain to reliably produce...
- unstable medical or psychiatric condition (e.g., mania, psychotic symptoms) that would interfere with study participation; or
- active suicidal ideation/intent indicating significant risk.
The study team makes the final eligibility decision.
Where it's taking place
- Seattle, Washington, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seattle, Washington, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.